Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty

This study has been completed.
Information provided by (Responsible Party):
Sangart Identifier:
First received: January 9, 2007
Last updated: August 15, 2013
Last verified: August 2013